| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
| Williams, Paige L |
Harvard School Of Public Health
United States |
Pediatric HIV/AIDS Cohort Study (PHACS) 2020 |
5P01HD103133-04 |
|
| Zhu, Yazhen |
University Of California Los Angeles
United States |
Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma |
5R01CA255727-04 |
|
| Hitchins, Megan P |
Cedars-Sinai Medical Center
United States |
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age |
5R01CA252042-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
| Panda, Satchidananda |
Salk Institute For Biological Studies
United States |
Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function |
3R01CA258221-03S1 |
RFA-CA-20-004 (R01 Clinical Trial Optional) |
| Peppone, Luke Joseph |
University Of Rochester
United States |
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
5R01CA258349-03 |
PAR-21-035 (R01 Clinical Trial Required) |
| Watt, Gordon Patrick |
Sloan-Kettering Inst Can Research
United States |
Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk |
1R37CA284134-01A1 |
|
| Infante, Rodney E |
Ut Southwestern Medical Center
United States |
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia |
5R01CA266900-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
| Carlsson, Sigrid |
Sloan-Kettering Inst Can Research
United States |
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
5U01CA266535-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |